Skip to content
← Retinoblastoma

FOR PATIENTS · SOURCE READING

Treatment of Progressive or Recurrent Retinoblastoma

Source: Retinoblastoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: October 7, 2021 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

For information about the treatments listed below, see the Treatment Option Overview section.

Source links and citations

Treatment of progressive or recurrent intraocular retinoblastoma may include the following:

Source links and citations

External-beam radiation therapy or plaque radiotherapy.

Source links and citations

Cryotherapy.

Source links and citations

Thermotherapy.

Source links and citations

Systemic chemotherapy or ophthalmic artery infusion chemotherapy.

Source links and citations

Intravitreal chemotherapy.

Source links and citations

Surgery (enucleation).

Source links and citations

A clinical trial of targeted therapy with an oncolytic virus that targets the RB1 gene and is injected into the tumor.

Source links and citations

A clinical trial that checks a sample of the patient's tumor for certain gene changes. The type of targeted therapy that will be given to the patient depends on the type of gene change.

Treatment of progressive or recurrent extraocular retinoblastoma may include the following:

Source links and citations

Systemic chemotherapy and external-beam radiation therapy for retinoblastoma that comes back after surgery to remove the eye.

Systemic chemotherapy followed by high-dose chemotherapy with stem cell rescue and external-beam radiation therapy.

Source links and citations

A clinical trial that checks a sample of the patient's tumor for certain gene changes. The type of targeted therapy that will be given to the patient depends on the type of gene change.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice